InsiderTradr

Wanbury Limited (WANBURY.BO)

BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic

₹175.85 (+5.30%) as of

Key statistics

Market cap
6.15B
P/E (TTM)
10.80
EPS (TTM)
16.28
Dividend yield
0.00%
52-week range
162.00 – 360.00
Beta
0.18
Revenue (TTM)
6.53B
Profit margin
8.56%
Volume
8.30k

About Wanbury Limited

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. It offers formulations for anti-infectives, pain and analgesics, gastroenterology, rheumatology, respiratory, gynecology, and central nervous system, as well as for vitamins, minerals, and nutrition. The company also provides API products for antidiabetics, antidepressants, anti-histaminic, anaesthetic, anti-inflammatory, anti-coagulant, GERD, and gastric ulcer therapy, as well as antitussives and analgesics. Its API portfolio includes Metformin Hcl, Sertraline Hcl, Tramadol Hcl, Mefenamic Acid, Metformin Hcl DC, Diphenhydramine Citrate, Paroxetine, Diphenhydramine Hcl, and Anaesthetic API. The company was founded in 1988 and is headquartered in Navi Mumbai, India.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Navi Mumbai, India
Employees
1,200

wanbury.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks